We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GlaxoSmithKline to Focus on Vaccines, Specialty Medicines
GlaxoSmithKline to Focus on Vaccines, Specialty Medicines
GlaxoSmithKline (GSK) yesterday unveiled plans for what it calls the “New GSK,” including focused investment in the development of vaccines and specialty medicines, which it predicts will make up the largest share of the company’s revenue within five years.